Status:
UNKNOWN
Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Federal University of Health Science of Porto Alegre
Conditions:
Fatigue
Leukemia
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Physiological changes caused by hematological diseases associated with high dose chemotherapy have a negative impact on patient's functionality, making them more fragile and vulnerable after hematopoi...
Detailed Description
The sample consists of 30 patients diagnosed with leukemia, lymphoma and multiple myeloma, undergoing high-dose chemotherapy and hematopoietic stem cells transplantation, who will be randomized into t...
Eligibility Criteria
Inclusion
- Adult patients (18-70 years) scheduled to perform the first HSCT;
- Be with a preserved neurological function and full cognition;
- Have clinical conditions that allow participation in the motor physiotherapy program;
- Be agreed with a study proposal and sign the free and informed consent form (ICF).
Exclusion
- Develop clinical complications that contraindicate the performance of motor physiotherapy including the practice of the cycle ergometer;
- Present a previous musculoskeletal alteration that interferes with the performance of physical performance assessment tests;
- Recent cardiovascular or pulmonary disease;
- Psychiatric or neurological disorder;
- Need for gait assistance or presence of bone metastasis
- Adherence below 50% of the total motor physiotherapy protocol.
Key Trial Info
Start Date :
March 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04496011
Start Date
March 2 2020
End Date
December 1 2020
Last Update
August 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA
Porto Alegre, Rio Grande do Sul, Brazil, 90050-170